Wu Y. Pembrolizumab in the Precision Immunotherapy of Sinonasal Malignancies. MS [Internet]. 2026 Aug. 13 [cited 2026 Oct. 23];4(4):7242. Available from: https://ms.deanfrancis.press/article/view/84